[HTML][HTML] Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study
…, HE Aschmann, A Domenghino, JS Fehr… - PloS one, 2021 - journals.plos.org
Background Longer-term consequences after SARS-CoV-2 infection are becoming an
important burden to societies and healthcare systems. Data on post-COVID-19 syndrome in the …
important burden to societies and healthcare systems. Data on post-COVID-19 syndrome in the …
Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study
…, A Domenghino, HE Aschmann, A Frei, JS Fehr… - bmj, 2023 - bmj.com
Objective To evaluate longer term symptoms and health outcomes associated with post-covid-19
condition within a cohort of individuals with a SARS-CoV-2 infection. Design …
condition within a cohort of individuals with a SARS-CoV-2 infection. Design …
[HTML][HTML] Septicemia caused by tick-borne bacterial pathogen Candidatus Neoehrlichia mikurensis
JS Fehr, GV Bloemberg, C Ritter… - Emerging infectious …, 2010 - ncbi.nlm.nih.gov
We have repeatedly detected Candidatus Neoehrlichia mikurensis, a bacterium first described
in Rattus norvegicus rats and Ixodes ovatus ticks in Japan in 2004 in the blood of a 61-…
in Rattus norvegicus rats and Ixodes ovatus ticks in Japan in 2004 in the blood of a 61-…
[HTML][HTML] Post COVID-19 condition, work ability and occupational changes in a population-based cohort
…, J Lacy, A Domenghino, JS Fehr… - The Lancet Regional …, 2023 - thelancet.com
Background Evidence on the impact of post COVID-19 condition (PCC) on work ability is
limited but critical due to its high prevalence among working-age individuals. This study aimed …
limited but critical due to its high prevalence among working-age individuals. This study aimed …
[HTML][HTML] Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
To better understand the development of SARS-CoV-2-specific immunity over time, a detailed
evaluation of humoral and cellular responses is required. Here, we characterize anti-Spike …
evaluation of humoral and cellular responses is required. Here, we characterize anti-Spike …
[HTML][HTML] Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: pooled analysis of two population-based cohorts
Background Post COVID-19 condition (PCC) is an important complication of SARS-CoV-2
infection, affecting millions worldwide. This study aimed to evaluate the prevalence and …
infection, affecting millions worldwide. This study aimed to evaluate the prevalence and …
A treatment-as-prevention trial to eliminate hepatitis C among men who have sex with men living with human immunodeficiency virus (HIV) in the Swiss HIV Cohort …
…, RD Kouyos, HF Günthard, JS Fehr - Clinical infectious …, 2021 - academic.oup.com
Background In 2016, the World Health Organization (WHO) introduced global targets for the
elimination of hepatitis C virus (HCV) by 2030. We conducted a nationwide HCV micro-…
elimination of hepatitis C virus (HCV) by 2030. We conducted a nationwide HCV micro-…
Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000–2016: a systematic review and meta-analysis
V Ghisla, AU Scherrer, D Nicca, DL Braun, JS Fehr - Infection, 2017 - Springer
Background There is a need for systematic reviews and meta-analyses to synthesize the
epidemiology, and the riskfactors for hepatitis C virus (HCV) among HIV-coinfected and HIV …
epidemiology, and the riskfactors for hepatitis C virus (HCV) among HIV-coinfected and HIV …
Sustained effect on hepatitis C elimination among men who have sex with men in the Swiss HIV Cohort Study: a systematic re-screening for hepatitis C RNA two years …
…, HF Günthard, J Böni, JS Fehr… - Clinical Infectious …, 2022 - academic.oup.com
Background The Swiss HCVree Trial (NCT 02785666) was conducted in 2015–2017 with
the goal of implementing a population-based systematic hepatitis C virus (HCV) micro-…
the goal of implementing a population-based systematic hepatitis C virus (HCV) micro-…
High cure rates with grazoprevir-elbasvir with or without ribavirin guided by genotypic resistance testing among human immunodeficiency virus/hepatitis C virus …
…, A Rauch, HF Günthard, J Böni, JS Fehr - Clinical infectious …, 2019 - academic.oup.com
Background This study was performed to investigate the efficacy and safety of grazoprevir-elbasvir
guided by baseline resistance-associated substitutions (RASs) in the Swiss HCVree …
guided by baseline resistance-associated substitutions (RASs) in the Swiss HCVree …